Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
14.08 USD | +2.33% | -1.88% | -21.56% |
Evolution of the average Target Price on REGENXBIO Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering REGENXBIO Inc.
HC Wainwright | |
UBS | |
RBC Capital Markets | |
Baird | |
Leerink Partners | |
Wedbush | |
Stifel Nicolaus | |
Morgan Stanley | |
Chardan Research | |
SVB Securities LLC | |
Berenberg Bank | |
SVB Leerink | |
Chardan | |
Barclays |
EPS Revisions
- Stock Market
- Equities
- RGNX Stock
- Consensus REGENXBIO Inc.